Hirokazu Saito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hirokazu Saito has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Shuji Tada
Department of Gastroenterology, Kumamoto City Hospital, Kumamoto City, Japan
20 shared publicationsIkuo Matsushita
18 shared publicationsTatsuyuki Kakuma
15 shared publicationsAtsushi Urata
13 shared publicationsKentaro Kamikawa
13 shared publicationsYoshihiro Kadono
13 shared publications
Latest Publications
- Open Access
- 30 July 2024
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 57  (4) , 508-514
Synergistic effect of independent risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis: a multicenter retrospective study in Japan
Background/Aims: This study aimed to examine the synergistic effect of independent risk factors on post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP).Methods: This multicenter retrospective study included 1,273 patients with native papillae who underwent ERCP for bile duct stones in Japan. Independent PEP risk factors were identified using univariate and multivariate analyses. Significant risk factors for PEP in the multivariate analysis were included in the final analysis to examine the synergistic effect of independent risk factors for PEP.Results: PEP occurred in 45 of 1,273 patients (3.5%). Three factors including difficult cannulation ≥10 minutes, pancreatic injection, and normal serum bilirubin level were included in the final analysis. The incidences of PEP in patients with zero, one, two, and three factors were 0.5% (2/388), 1.9% (9/465), 6.0% (17/285), and 12.6% (17/135), respectively. With increasing risk factors for PEP, the incidence of PEP significantly increased (1 factor vs. 2 factors, p=0.006; 2 factors vs. 3 factors, p=0.033).Conclusions: As the number of risk factors for PEP increases, the risk of PEP may not be additive; however, it may multiply. Thus, aggressive prophylaxis for PEP is strongly recommended in patients with multiple risk factors.
- 30 July 2024
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 57  (4) , 508-514
Open AccessSynergistic effect of independent risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis: a multicenter retrospective study in Japan
Background/Aims: This study aimed to examine the synergistic effect of independent risk factors on post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP).Methods: This multicenter retrospective study included 1,273 patients with native papillae who underwent ERCP for bile duct stones in Japan. Independent PEP risk factors were identified using univariate and multivariate analyses. Significant risk factors for PEP in the multivariate analysis were included in the final analysis to examine the synergistic effect of independent risk factors for PEP.Results: PEP occurred in 45 of 1,273 patients (3.5%). Three factors including difficult cannulation ≥10 minutes, pancreatic injection, and normal serum bilirubin level were included in the final analysis. The incidences of PEP in patients with zero, one, two, and three factors were 0.5% (2/388), 1.9% (9/465), 6.0% (17/285), and 12.6% (17/135), respectively. With increasing risk factors for PEP, the incidence of PEP significantly increased (1 factor vs. 2 factors, p=0.006; 2 factors vs. 3 factors, p=0.033).Conclusions: As the number of risk factors for PEP increases, the risk of PEP may not be additive; however, it may multiply. Thus, aggressive prophylaxis for PEP is strongly recommended in patients with multiple risk factors.
- 30 November 2023
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 17  (1) , 6-11
Sublingual immunotherapy for cedar pollinosis possibly triggers eosinophilic esophagitis
Sublingual immunotherapy (SLIT) is an effective and popular treatment for cedar pollinosis. Although SLIT can cause allergic side effects, eosinophilic esophagitis (EoE) is a lesser-known side effect of SLIT. A 26-year-old male with cedar pollinosis, wheat-dependent exercise-induced anaphylaxis, and food allergies to bananas and avocados presented with persistent throat itching, difficulty swallowing, heartburn, and anterior chest pain 8 days after starting SLIT for cedar pollinosis. Laboratory examination showed remarkably elevated eosinophils, and esophagogastroduodenoscopy revealed linear furrows in the entire esophagus. Histological examination of an esophageal biopsy specimen revealed high eosinophil levels. The patient was strongly suspected with EoE triggered by SLIT. The patient was advised to switch from the swallow to the spit method for SLIT, and the symptoms associated with SLIT-triggered EoE were reduced after switching to the spit method. This case highlights the importance of recognizing SLIT-triggered EoE as a potential side effect of SLIT for cedar pollinosis, especially with the increasing use of SLIT in clinical practice. EoE can occur within a month after initiating SLIT in patients with multiple allergic conditions, as observed in our case. Furthermore, the spit method should be recommended for patients who experience SLIT-triggered EoE before discontinuing SLIT.
- 30 November 2023
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 17  (1) , 6-11
Sublingual immunotherapy for cedar pollinosis possibly triggers eosinophilic esophagitis
Sublingual immunotherapy (SLIT) is an effective and popular treatment for cedar pollinosis. Although SLIT can cause allergic side effects, eosinophilic esophagitis (EoE) is a lesser-known side effect of SLIT. A 26-year-old male with cedar pollinosis, wheat-dependent exercise-induced anaphylaxis, and food allergies to bananas and avocados presented with persistent throat itching, difficulty swallowing, heartburn, and anterior chest pain 8 days after starting SLIT for cedar pollinosis. Laboratory examination showed remarkably elevated eosinophils, and esophagogastroduodenoscopy revealed linear furrows in the entire esophagus. Histological examination of an esophageal biopsy specimen revealed high eosinophil levels. The patient was strongly suspected with EoE triggered by SLIT. The patient was advised to switch from the swallow to the spit method for SLIT, and the symptoms associated with SLIT-triggered EoE were reduced after switching to the spit method. This case highlights the importance of recognizing SLIT-triggered EoE as a potential side effect of SLIT for cedar pollinosis, especially with the increasing use of SLIT in clinical practice. EoE can occur within a month after initiating SLIT in patients with multiple allergic conditions, as observed in our case. Furthermore, the spit method should be recommended for patients who experience SLIT-triggered EoE before discontinuing SLIT.
- 7 October 2023
- Published by S. Karger AG in Digestive Diseases
- Vol. 42  (1) , 87-93
Comparison of Outcomes between a Basket Catheter and a Balloon Catheter for Endoscopic Common Bile Duct Stone Removal
Introduction: Evidence for the outcomes of endoscopic retrograde cholangiopancreatography (ERCP) between a basket catheter and a balloon catheter for endoscopic common bile duct stone (CBDS) removal is lacking. This study aimed to compare ERCP outcomes using a basket catheter and a balloon catheter for endoscopic CBDS removal. Methods: This multicenter retrospective study included 904 consecutive patients with native papilla who underwent endoscopic stone removal for CBDS ≤10 mm using a basket catheter and/or a balloon catheter at three institutions in Japan. ERCP outcomes between the basket and balloon groups were compared using inverse probability of treatment weighting (IPTW) method. Results: ERCP-related adverse events occurred in 6.5% (29/449) and 7.7% (35/455) of patients in the basket and balloon groups, respectively (IPTW-adjusted p = 0.52). The incidences of post-ERCP pancreatitis, cholangitis, and perforation were similar in the basket and balloon groups (3.8% vs. 2.9%, 1.3% vs. 0.9%, and 0.7% vs. 0.7%, respectively). However, bleeding incidences were significantly higher in the balloon group than in the basket group (3.3% vs. 0.7%, IPTW-adjusted p = 0.012). Successful complete stone removal at one ERCP session using a single catheter was achieved in 17.8% (80/449) in the basket group and in 81.3% (370/455) in the balloon group (IPTW-adjusted p < 0.001). Discussion: A balloon catheter is more likely to complete stone extraction for CBDS ≤10 mm with a single catheter at one endoscopic stone removal session. However, the risk for post-ERCP bleeding is higher in the balloon group than in the basket group.
- 7 October 2023
- Published by S. Karger AG in Digestive Diseases
- Vol. 42  (1) , 87-93
Comparison of Outcomes between a Basket Catheter and a Balloon Catheter for Endoscopic Common Bile Duct Stone Removal
Introduction: Evidence for the outcomes of endoscopic retrograde cholangiopancreatography (ERCP) between a basket catheter and a balloon catheter for endoscopic common bile duct stone (CBDS) removal is lacking. This study aimed to compare ERCP outcomes using a basket catheter and a balloon catheter for endoscopic CBDS removal. Methods: This multicenter retrospective study included 904 consecutive patients with native papilla who underwent endoscopic stone removal for CBDS ≤10 mm using a basket catheter and/or a balloon catheter at three institutions in Japan. ERCP outcomes between the basket and balloon groups were compared using inverse probability of treatment weighting (IPTW) method. Results: ERCP-related adverse events occurred in 6.5% (29/449) and 7.7% (35/455) of patients in the basket and balloon groups, respectively (IPTW-adjusted p = 0.52). The incidences of post-ERCP pancreatitis, cholangitis, and perforation were similar in the basket and balloon groups (3.8% vs. 2.9%, 1.3% vs. 0.9%, and 0.7% vs. 0.7%, respectively). However, bleeding incidences were significantly higher in the balloon group than in the basket group (3.3% vs. 0.7%, IPTW-adjusted p = 0.012). Successful complete stone removal at one ERCP session using a single catheter was achieved in 17.8% (80/449) in the basket group and in 81.3% (370/455) in the balloon group (IPTW-adjusted p < 0.001). Discussion: A balloon catheter is more likely to complete stone extraction for CBDS ≤10 mm with a single catheter at one endoscopic stone removal session. However, the risk for post-ERCP bleeding is higher in the balloon group than in the basket group.
- 14 July 2023
- Published by Wiley in Digestive Endoscopy
- Vol. 35  (6) , E113-E114
En face position of the major duodenal papilla using a reopenable clip during endoscopic retrograde cholangiopancreatography
Watch a video of this article.
- 14 July 2023
- Published by Wiley in Digestive Endoscopy
- Vol. 35  (6) , E113-E114
En face position of the major duodenal papilla using a reopenable clip during endoscopic retrograde cholangiopancreatography
Watch a video of this article.
- Open Access
- 30 March 2023
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 56  (2) , 256-257
Side-viewing scope insertion using a large-diameter overtube designed for colonoscopy in a patient with a cascade stomach
Endoscopic retrograde cholangiopancreatography (ERCP) is an invaluable procedure for managing biliopancreatic disorders. Successful side-viewing scope insertion into the descending part of the duodenum is the first step in ERCP. However, delivering the side-viewing scope into the descending part of the duodenum is difficult in some patients with a cascade stomach, as the scope is in the Forced of a side-viewing scope in such patients may tear the gastric mucosa and result in gastric perforation and bleeding due to excessive shearing force on the gastric wall. 1,2 To overcome this problem, we used a large-diameter overtube designed for colonoscopy in patients in whom side-viewing scope insertion into the descending part of the duodenum was difficult due to a cascade stomach. An 88-year-old man who had required biliary stent insertion for acute cholangitis caused by bile duct stones 2 months prior was admitted to our hospital for removal of the biliary stent and bile duct stones. However, scope insertion into the descending part of the duodenum using a side-viewing endoscope (TJF-260V; Olympus, Tokyo, Japan) during ERCP was difficult
- 30 March 2023
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 56  (2) , 256-257
Open AccessSide-viewing scope insertion using a large-diameter overtube designed for colonoscopy in a patient with a cascade stomach
Endoscopic retrograde cholangiopancreatography (ERCP) is an invaluable procedure for managing biliopancreatic disorders. Successful side-viewing scope insertion into the descending part of the duodenum is the first step in ERCP. However, delivering the side-viewing scope into the descending part of the duodenum is difficult in some patients with a cascade stomach, as the scope is in the Forced of a side-viewing scope in such patients may tear the gastric mucosa and result in gastric perforation and bleeding due to excessive shearing force on the gastric wall. 1,2 To overcome this problem, we used a large-diameter overtube designed for colonoscopy in patients in whom side-viewing scope insertion into the descending part of the duodenum was difficult due to a cascade stomach. An 88-year-old man who had required biliary stent insertion for acute cholangitis caused by bile duct stones 2 months prior was admitted to our hospital for removal of the biliary stent and bile duct stones. However, scope insertion into the descending part of the duodenum using a side-viewing endoscope (TJF-260V; Olympus, Tokyo, Japan) during ERCP was difficult
- 27 February 2023
- Published by Springer Nature in Surgical Endoscopy
- Vol. 37  (6) , 4585-4593
Unnecessary endoscopic retrograde cholangiopancreatography associated with the spontaneous passage of common bile duct stones into the duodenum: a multicenter retrospective study
Background Unnecessary endoscopic retrograde cholangiopancreatography (ERCP) after spontaneous passage of common bile duct stones (CBDSs) should be avoided. This study aimed to examine the cumulative diagnosis rate and the predictive factors of spontaneous CBDS passage during the interval between the imaging diagnosis and ERCP. Methods This multicenter retrospective study included 1260 consecutive patients with native papilla diagnosed with CBDSs using imaging modalities. Predictive factors and cumulative diagnosis rate of spontaneously passed CBDSs during the interval between imaging diagnosis and ERCP were analyzed. Results The overall cumulative diagnosis rate of spontaneous CBDS passage was 6.2% (78/1260) during a mean interval of 5.0 days. In the multivariate analysis, CBDS sized < 6 mm on diagnostic imaging, solitary CBDS on diagnostic imaging, intervals between the imaging diagnosis and ERCP, and nondilated common bile duct (< 10 mm) were the significant factors associated with spontaneous CBDS passage. Specifically, the cumulative diagnosis rate of spontaneous passage was significantly higher in patients with solitary and CBDSs sized < 6 mm than in those with other CBDSs (14.4% [54/376] vs. 2.7% [24/884], P < 0.001). In both the asymptomatic and symptomatic groups, the cumulative diagnosis rate of the spontaneous passage of CBDSs was significantly higher in patients with solitary and CBDSs sized < 6 mm on diagnostic imaging than in those with multiple and/or CBDSs sized ≥ 6 mm on diagnostic imaging during a mean interval of 20.5 and 2.4 days, respectively (asymptomatic group: 22.4% [15/67] vs. 3.5% [4/113], P < 0.001, symptomatic group: 12.6% [39/309] vs. 2.6% [20/771], P < 0.001). Conclusions Solitary and CBDSs sized < 6 mm on diagnostic imaging can often lead unnecessary ERCP due to spontaneous passage. Preliminary endoscopic ultrasonography immediately before ERCP is recommended, especially in patients with solitary and small CBDSs on diagnostic imaging.
- 27 February 2023
- Published by Springer Nature in Surgical Endoscopy
- Vol. 37  (6) , 4585-4593
Unnecessary endoscopic retrograde cholangiopancreatography associated with the spontaneous passage of common bile duct stones into the duodenum: a multicenter retrospective study
Background Unnecessary endoscopic retrograde cholangiopancreatography (ERCP) after spontaneous passage of common bile duct stones (CBDSs) should be avoided. This study aimed to examine the cumulative diagnosis rate and the predictive factors of spontaneous CBDS passage during the interval between the imaging diagnosis and ERCP. Methods This multicenter retrospective study included 1260 consecutive patients with native papilla diagnosed with CBDSs using imaging modalities. Predictive factors and cumulative diagnosis rate of spontaneously passed CBDSs during the interval between imaging diagnosis and ERCP were analyzed. Results The overall cumulative diagnosis rate of spontaneous CBDS passage was 6.2% (78/1260) during a mean interval of 5.0 days. In the multivariate analysis, CBDS sized < 6 mm on diagnostic imaging, solitary CBDS on diagnostic imaging, intervals between the imaging diagnosis and ERCP, and nondilated common bile duct (< 10 mm) were the significant factors associated with spontaneous CBDS passage. Specifically, the cumulative diagnosis rate of spontaneous passage was significantly higher in patients with solitary and CBDSs sized < 6 mm than in those with other CBDSs (14.4% [54/376] vs. 2.7% [24/884], P < 0.001). In both the asymptomatic and symptomatic groups, the cumulative diagnosis rate of the spontaneous passage of CBDSs was significantly higher in patients with solitary and CBDSs sized < 6 mm on diagnostic imaging than in those with multiple and/or CBDSs sized ≥ 6 mm on diagnostic imaging during a mean interval of 20.5 and 2.4 days, respectively (asymptomatic group: 22.4% [15/67] vs. 3.5% [4/113], P < 0.001, symptomatic group: 12.6% [39/309] vs. 2.6% [20/771], P < 0.001). Conclusions Solitary and CBDSs sized < 6 mm on diagnostic imaging can often lead unnecessary ERCP due to spontaneous passage. Preliminary endoscopic ultrasonography immediately before ERCP is recommended, especially in patients with solitary and small CBDSs on diagnostic imaging.
- Open Access
- 4 January 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55  (S 01) , E654-E655
Use of a novel biliary stent to prevent distal stent migration in benign anastomotic stricture
Endoscopic treatment using balloon enteroscopy-assisted endoscopic retrograde cholangiopancreatography (ERCP) is useful for hepaticojejunostomy anastomotic strictures. Although biliary stent placement is conducted to avoid stricture recurrence or realize stricture resolution after balloon dilation [1] [2], distal stent migration is a common problem [3] [4]. An 11-year-old-boy, who had undergone hepaticojejunostomy for pancreaticobiliary maljunction 1 year earlier, underwent single-balloon endoscope-assisted ERCP to resolve a benign anastomotic stricture ([Fig. 1 a]). After balloon dilation, a 7-Fr straight-type plastic stent was placed into the intrahepatic bile duct to prevent stricture recurrence ([Fig. 1 b]). However, distal stent migration occurred at 4 weeks after the procedure. We used a novel 7-Fr Tanenbaum-type biliary stent integrated with a nasobiliary drainage catheter (UMIZAS NB STENT; Olympus Medical System, Tokyo, Japan) to prevent distal stent migration ([Fig. 2 a]). As the attached pusher catheter was too short to place the stent using a short-type enteroscope (SIF-H290S; Olympus Medical System), the outer sheath of a snare designed for the colon (Snare Master; Olympus Medical System) was used as the pusher catheter. First, we cut the outer sheath of the snare at the proximal side ([Fig. 2 b], [Video 1]) and covered the nasobiliary drainage catheter with the outer sheath of the snare after withdrawing the associated pusher catheter. The inner nasobiliary catheter protruded approximately 15 mm from the tip of the stent, and the outer sheath and nasobiliary catheter were fixed with tape. The nasobiliary catheter and outer sheath were removed after the 7-Fr biliary stent was placed into the intrahepatic duct ([Fig. 2 c]). After 3 months, there was no evidence of distal stent migration. Video 1 Use of a novel outside biliary stent with the outer sheath of a snare designed for the colon to avoid distal stent migration for a benign hepaticojejunostomy anastomotic stricture. To reduce distal stent migration, a unique 7-Fr biliary stent integrated with a nasobiliary drainage catheter using the outer sheath of a snare designed for the colon may be helpful in surgically altered anatomy. Endoscopy_UCTN_Code_TTT_1AR_2AZ Article published online: 21 April 2023 © 2023. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 4 January 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55  (S 01) , E654-E655
Open AccessUse of a novel biliary stent to prevent distal stent migration in benign anastomotic stricture
Endoscopic treatment using balloon enteroscopy-assisted endoscopic retrograde cholangiopancreatography (ERCP) is useful for hepaticojejunostomy anastomotic strictures. Although biliary stent placement is conducted to avoid stricture recurrence or realize stricture resolution after balloon dilation [1] [2], distal stent migration is a common problem [3] [4]. An 11-year-old-boy, who had undergone hepaticojejunostomy for pancreaticobiliary maljunction 1 year earlier, underwent single-balloon endoscope-assisted ERCP to resolve a benign anastomotic stricture ([Fig. 1 a]). After balloon dilation, a 7-Fr straight-type plastic stent was placed into the intrahepatic bile duct to prevent stricture recurrence ([Fig. 1 b]). However, distal stent migration occurred at 4 weeks after the procedure. We used a novel 7-Fr Tanenbaum-type biliary stent integrated with a nasobiliary drainage catheter (UMIZAS NB STENT; Olympus Medical System, Tokyo, Japan) to prevent distal stent migration ([Fig. 2 a]). As the attached pusher catheter was too short to place the stent using a short-type enteroscope (SIF-H290S; Olympus Medical System), the outer sheath of a snare designed for the colon (Snare Master; Olympus Medical System) was used as the pusher catheter. First, we cut the outer sheath of the snare at the proximal side ([Fig. 2 b], [Video 1]) and covered the nasobiliary drainage catheter with the outer sheath of the snare after withdrawing the associated pusher catheter. The inner nasobiliary catheter protruded approximately 15 mm from the tip of the stent, and the outer sheath and nasobiliary catheter were fixed with tape. The nasobiliary catheter and outer sheath were removed after the 7-Fr biliary stent was placed into the intrahepatic duct ([Fig. 2 c]). After 3 months, there was no evidence of distal stent migration. Video 1 Use of a novel outside biliary stent with the outer sheath of a snare designed for the colon to avoid distal stent migration for a benign hepaticojejunostomy anastomotic stricture. To reduce distal stent migration, a unique 7-Fr biliary stent integrated with a nasobiliary drainage catheter using the outer sheath of a snare designed for the colon may be helpful in surgically altered anatomy. Endoscopy_UCTN_Code_TTT_1AR_2AZ Article published online: 21 April 2023 © 2023. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 4 January 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55  (S 01) , E448-E449
Ruptured cystic artery pseudoaneurysm after long-term transpapillary placement of a gallbladder stent for acute cholecystitis
Endoscopic transpapillary gallbladder drainage (ETGBD), including endoscopic gallbladder stenting (EGBS), has utility in the management of acute cholecystitis in patients considered to be high risk candidates for surgery [1]. A recent meta-analysis reported that the pooled rate of cholecystitis recurrence was 4.6 % following ETGBD in patients with acute cholecystitis [2]. Long-term biliary drainage via EGBS is often performed to prevent the recurrence of cholecystitis in patients with contraindications to cholecystectomy. An 88-year-old man was admitted with acute cholangitis after undergoing EGBS due to an episode of acute cholecystitis 8 months prior with placement of a 7-Fr double-pigtail stent (Through & Pass double pigtail stent; Gadelius Medical, Japan) as he was considered a high risk candidate for cholecystectomy. Scheduled stent exchanges using a similar stent had been performed at 3-month intervals after initial EGBS to prevent the recurrence of cholecystitis. Computed tomography demonstrated bleeding from the biliary tract ([Fig. 1 a]). Hemobilia was observed during endoscopic retrograde cholangiopancreatography (ERCP) and blood clots were endoscopically removed from the bile duct. Insertion of a 0.025-inch guidewire (VisiGlide 2 with angled tip; Olympus Medical Systems, Tokyo, Japan) into the gallbladder resulted in blood flow from the ampulla of Vater ([Fig. 1 b, c]; [Video 1]). The ERCP procedure was therefore abandoned and a ruptured cystic artery pseudoaneurysm immediately adjacent to the stent biliary stent was identified on contrast-enhanced computed tomography ([Fig. 2 a, b]). Transcatheter arterial coil embolization was successfully performed to control bleeding from the ruptured cystic artery pseudoaneurysm without complications. Open cholecystectomy was performed 2 weeks after coil embolization. Video 1 Ruptured cystic artery pseudoaneurysm after long-term endoscopic transpapillary gallbladder stent placement in a patient with acute cholecystitis. This is the first report of a ruptured cystic artery pseudoaneurysm associated with EGBS which we strongly suspect was due to long‑term compression of the cystic artery leading to formation of a cystic artery pseudoaneurysm. Our findings highlight the risk of cystic artery pseudoaneurysm formation in patients with long-term transpapillary placement of a gallbladder stent, even when scheduled stent exchanges are performed. Endoscopy_UCTN_Code_CPL_1AK_2AI Article published online: 16 February 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 4 January 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55  (S 01) , E448-E449
Open AccessRuptured cystic artery pseudoaneurysm after long-term transpapillary placement of a gallbladder stent for acute cholecystitis
Endoscopic transpapillary gallbladder drainage (ETGBD), including endoscopic gallbladder stenting (EGBS), has utility in the management of acute cholecystitis in patients considered to be high risk candidates for surgery [1]. A recent meta-analysis reported that the pooled rate of cholecystitis recurrence was 4.6 % following ETGBD in patients with acute cholecystitis [2]. Long-term biliary drainage via EGBS is often performed to prevent the recurrence of cholecystitis in patients with contraindications to cholecystectomy. An 88-year-old man was admitted with acute cholangitis after undergoing EGBS due to an episode of acute cholecystitis 8 months prior with placement of a 7-Fr double-pigtail stent (Through & Pass double pigtail stent; Gadelius Medical, Japan) as he was considered a high risk candidate for cholecystectomy. Scheduled stent exchanges using a similar stent had been performed at 3-month intervals after initial EGBS to prevent the recurrence of cholecystitis. Computed tomography demonstrated bleeding from the biliary tract ([Fig. 1 a]). Hemobilia was observed during endoscopic retrograde cholangiopancreatography (ERCP) and blood clots were endoscopically removed from the bile duct. Insertion of a 0.025-inch guidewire (VisiGlide 2 with angled tip; Olympus Medical Systems, Tokyo, Japan) into the gallbladder resulted in blood flow from the ampulla of Vater ([Fig. 1 b, c]; [Video 1]). The ERCP procedure was therefore abandoned and a ruptured cystic artery pseudoaneurysm immediately adjacent to the stent biliary stent was identified on contrast-enhanced computed tomography ([Fig. 2 a, b]). Transcatheter arterial coil embolization was successfully performed to control bleeding from the ruptured cystic artery pseudoaneurysm without complications. Open cholecystectomy was performed 2 weeks after coil embolization. Video 1 Ruptured cystic artery pseudoaneurysm after long-term endoscopic transpapillary gallbladder stent placement in a patient with acute cholecystitis. This is the first report of a ruptured cystic artery pseudoaneurysm associated with EGBS which we strongly suspect was due to long‑term compression of the cystic artery leading to formation of a cystic artery pseudoaneurysm. Our findings highlight the risk of cystic artery pseudoaneurysm formation in patients with long-term transpapillary placement of a gallbladder stent, even when scheduled stent exchanges are performed. Endoscopy_UCTN_Code_CPL_1AK_2AI Article published online: 16 February 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 1 January 2023
- Published by Japan Medical Association in JMA Journal
- Vol. 6  (2) , 156-164
Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis after Conservative Treatment for Symptomatic Bile Duct Stones
Introduction: Endoscopic retrograde cholangiopancreatography (ERCP) for asymptomatic common bile duct stones (CBDS) has been associated with an increased risk of post-ERCP pancreatitis (PEP). Patients with asymptomatic CBDS at the time of ERCP include those with incidentally discovered CBDS (group A) and previously symptomatic patients with CBDS who became asymptomatic after conservative treatment for symptomatic CBDS, including obstructive jaundice or acute cholangitis (group B). In this study, we aimed to examine PEP risk in group B by comparing PEP risks between groups A, B, and currently symptomatic patients (group C). Methods: In this multicenter retrospective study, we examined 77 patients in group A, 41 patients in group B, and 1225 patients in group C who had native papillae. PEP incidence rates between asymptomatic patients at the time of ERCP (groups A and B) and symptomatic patients (group C) were compared using one-to-one propensity score matching. Bonfer-roni's correction analysis was also performed to compare PEP incidence rates among the three groups. Results: As per our findings, PEP incidence rate in propensity score-matched groups A and B was significantly higher than that of propensity score-matched group C (13.2% [15/114] versus 4.4% [5/114], respectively, P = 0.033). In groups A and B, PEP incidence rates were 11.7% (9/77) and 14.6% (6/41), respectively. PEP risk in group B was similar to that in group A (P = 1.0). PEP incidence in group B was significantly higher than PEP incidence in group C (14.6% (6/41)) vs. 2.9% (35/1225)) (P = 0.005)). Conclusions: ERCP for previously symptomatic patients with CBDS who became asymptomatic after conservative treat-ment for symptomatic CBDS may increase the risk of PEP compared with ERCP for currently symptomatic patients. Thus, ERCP should be performed before patients become asymptomatic using conservative treatments if patients can toler-ate ERCP procedures.
- 1 January 2023
- Published by Japan Medical Association in JMA Journal
- Vol. 6  (2) , 156-164
Open AccessPost-endoscopic Retrograde Cholangiopancreatography Pancreatitis after Conservative Treatment for Symptomatic Bile Duct Stones
Introduction: Endoscopic retrograde cholangiopancreatography (ERCP) for asymptomatic common bile duct stones (CBDS) has been associated with an increased risk of post-ERCP pancreatitis (PEP). Patients with asymptomatic CBDS at the time of ERCP include those with incidentally discovered CBDS (group A) and previously symptomatic patients with CBDS who became asymptomatic after conservative treatment for symptomatic CBDS, including obstructive jaundice or acute cholangitis (group B). In this study, we aimed to examine PEP risk in group B by comparing PEP risks between groups A, B, and currently symptomatic patients (group C). Methods: In this multicenter retrospective study, we examined 77 patients in group A, 41 patients in group B, and 1225 patients in group C who had native papillae. PEP incidence rates between asymptomatic patients at the time of ERCP (groups A and B) and symptomatic patients (group C) were compared using one-to-one propensity score matching. Bonfer-roni's correction analysis was also performed to compare PEP incidence rates among the three groups. Results: As per our findings, PEP incidence rate in propensity score-matched groups A and B was significantly higher than that of propensity score-matched group C (13.2% [15/114] versus 4.4% [5/114], respectively, P = 0.033). In groups A and B, PEP incidence rates were 11.7% (9/77) and 14.6% (6/41), respectively. PEP risk in group B was similar to that in group A (P = 1.0). PEP incidence in group B was significantly higher than PEP incidence in group C (14.6% (6/41)) vs. 2.9% (35/1225)) (P = 0.005)). Conclusions: ERCP for previously symptomatic patients with CBDS who became asymptomatic after conservative treat-ment for symptomatic CBDS may increase the risk of PEP compared with ERCP for currently symptomatic patients. Thus, ERCP should be performed before patients become asymptomatic using conservative treatments if patients can toler-ate ERCP procedures.
- 30 November 2022
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 68  (5) , 2061-2068
Low Detection Rates of Bile Duct Stones During Endoscopic Treatment for Highly Suspected Bile Duct Stones with No Imaging Evidence of Stones
Background The revised American Society for Gastrointestinal Endoscopy (ASGE) guideline 2019 provides the high-risk criteria for suspected common bile duct stones (CBDSs). Aims To evaluate CBDS detection rates during endoscopic retrograde cholangiopancreatography (ERCP) in high-risk patients with suspected CBDSs based on the ASGE guideline 2019. Methods This multicenter retrospective study included 1100 consecutive patients who underwent ERCP for suspected CBDSs with any high-risk criteria based on the revised ASGE guideline 2019: Criterion 1, CBDSs on imaging; Criterion 2, clinical ascending cholangitis; and Criterion 3, total bilirubin exceeding 4 mg/dL and dilated common bile duct on imaging. We compared CBDS detection rates during ERCP based on individual and combined high-risk criteria. Results The CBDS detection rates of patients who met any of the criteria, only Criterion 1, and Criteria 2 or 3 were 86.0% (946/1100), 93.4% (113/121), and 50.0% (106/212), respectively. In patients who met Criteria 1 and 2, 1 and 3, 2 and 3, and all criteria, CBDSs were confirmed during ERCP in 95.1% (490/515), 96.2% (25/26), 55.3% (26/47), and 98.4% (186/189), respectively. The CBDS detection rate during ERCP of patients with at least Criterion 1 significantly exceeded that of patients without at least Criterion 1 [95.7% (814/851) vs. 51.0% (132/259), respectively, P < 0.001]. Conclusions Patients with CBDS visualization on imaging have very high CBDS detection rates during ERCP. However, performing ERCP on patients with only clinical predictors, such as cholangitis and dilated CBD with total bilirubin exceeding 4 mg/dL, often results in unnecessary ERCP.
- 30 November 2022
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 68  (5) , 2061-2068
Low Detection Rates of Bile Duct Stones During Endoscopic Treatment for Highly Suspected Bile Duct Stones with No Imaging Evidence of Stones
Background The revised American Society for Gastrointestinal Endoscopy (ASGE) guideline 2019 provides the high-risk criteria for suspected common bile duct stones (CBDSs). Aims To evaluate CBDS detection rates during endoscopic retrograde cholangiopancreatography (ERCP) in high-risk patients with suspected CBDSs based on the ASGE guideline 2019. Methods This multicenter retrospective study included 1100 consecutive patients who underwent ERCP for suspected CBDSs with any high-risk criteria based on the revised ASGE guideline 2019: Criterion 1, CBDSs on imaging; Criterion 2, clinical ascending cholangitis; and Criterion 3, total bilirubin exceeding 4 mg/dL and dilated common bile duct on imaging. We compared CBDS detection rates during ERCP based on individual and combined high-risk criteria. Results The CBDS detection rates of patients who met any of the criteria, only Criterion 1, and Criteria 2 or 3 were 86.0% (946/1100), 93.4% (113/121), and 50.0% (106/212), respectively. In patients who met Criteria 1 and 2, 1 and 3, 2 and 3, and all criteria, CBDSs were confirmed during ERCP in 95.1% (490/515), 96.2% (25/26), 55.3% (26/47), and 98.4% (186/189), respectively. The CBDS detection rate during ERCP of patients with at least Criterion 1 significantly exceeded that of patients without at least Criterion 1 [95.7% (814/851) vs. 51.0% (132/259), respectively, P < 0.001]. Conclusions Patients with CBDS visualization on imaging have very high CBDS detection rates during ERCP. However, performing ERCP on patients with only clinical predictors, such as cholangitis and dilated CBD with total bilirubin exceeding 4 mg/dL, often results in unnecessary ERCP.